Recognition of herpesviruses by the innate immune system

Nature Reviews Immunology

Volumn 11, Issue 2, 2011, Pages 143-154

  Paludan, Sã̧ Ren ^a   Bowie, Andrew G ^b   Horan, Kristy A ^a   Fitzgerald, Katherine A ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DEAH BOX PROTEIN 36; DEAH BOX PROTEIN 9; DNA DIRECTED RNA POLYMERASE III; HELICASE; INTERFERON GAMMA INDUCIBLE PROTEIN 16; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; PATTERN RECOGNITION RECEPTOR; PROTEIN AIM2; PROTEIN DAI; PROTEIN KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANTIGEN RECOGNITION; CELL SURFACE; CYTOSOL; ENDOSOME; HERPES VIRUS; HERPES VIRUS INFECTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTRACELLULAR SPACE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 79251477166     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2937     Document Type: Review

References (140)

1. Pellett, P. E. & Roizman, B. The Family: Herpesviridae A Brief Introduction in Fields Virology 2479-2500 (Lippincort, Williams & Wilkins, Philadelphia, 2007).
2. Liu, T., Khanna, K. M., Chen, X., Fink, D. J. & Hendricks, R. L. CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191, 1459-1466 (2000).
3. Liu, T., Khanna, K. M., Carriere, B. N. & Hendricks, R. L. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75, 11178-11184 (2001).
4. Reusser, P., Riddell, S. R., Meyers, J. D. & Greenberg, P. D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380 (1991).
5. Braaten, D. C., Sparks-Thissen, R. L., Kreher, S., Speck, S. H. & Virgin, H. W. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J. Virol. 79, 2573-2583 (2005).
6. Dupuis, S. et al. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nature Genet. 33, 388-391 (2003). This paper showed that patients with STAT1 deficiency do not respond to type I IFNs and are susceptible to herpes simplex virus encephalitis.
7. Salazar-Mather, T. P., Lewis, C. A. & Biron, C. A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J. Clin. Invest. 110, 321-330 (2002).
8. Biron, C. A., Byron, K. S. & Sullivan, J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320, 1731-1735 (1989).
9. Rager-Zisman, B., Quan, P. C., Rosner, M., Moller, J. R. & Bloom, B. R. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 138, 884-888 (1987).
10. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
11. Schlee, M. et al. Recognition of 5 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25-34 (2009).
12. Schmidt, A. et al. 5-triphosphate RNA requires basepaired structures to activate antiviral signaling via RIG-I. Proc. Natl Acad. Sci. USA 106, 12067-12072 (2009).
13. Pichlmair, A. et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83, 10761-10769 (2009).
14. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501-505 (2007). DAI was the first cytoplasmic DNA sensor to be identified, and was shown to contribute to the type I IFN response to HSV-1 infection.
15. Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518 (2009).
16. Burckstummer, T. et al. An orthogonal proteomicgenomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nature Immunol. 10, 266-272 (2009).
17. Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513 (2009).
18. Roberts, T. L. et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323, 1057-1060 (2009).
19. Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nature Immunol. 10, 1065-1072 (2009).
20. Chiu, Y. H., Macmillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591 (2009).
21. Yang, P. et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a β-catenin-dependent pathway. Nature Immunol. 11, 487-494 (2010).
22. Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nature Immunol. 11, 997-1004 (2010).
23. Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production. Nature Immunol. 11, 63-69 (2010).
24. Mogensen, T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240-273 (2009).
25. Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic patternrecognition receptors. Nature Rev. Immunol. 6, 644-658 (2006).
26. Gugliesi, F. et al. The proapoptotic activity of the interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. J. Autoimmun. 35, 114-123 (2010).
27. Chandran, B. Early events in Kaposi's sarcomaassociated herpesvirus infection of target cells. J. Virol. 84, 2188-2199 (2010).
28. Melroe, G. T., DeLuca, N. A. & Knipe, D. M. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78, 8411-8420 (2004).
29. Cristea, I. M. et al. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J. Virol. 84, 7803-7814 (2010).
30. Cotter, C. R. et al. The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells. PLoS oNE 5, e8684 (2010).
31. Rebsamen, M. et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB. EMBo Rep. 10, 916-922 (2009).
32. Wu, L. et al. Epstein-Barr virus LF2: an antagonist to type I interferon. J. Virol. 83, 1140-1146 (2009).
33. van Lint, A. L. et al. Herpes simplex virus immediateearly ICP0 protein inhibits TLR2-dependent inflammatory responses and NF-κB signaling. J. Virol. 84, 10802-10811 (2010).
34. Orvedahl, A. et al. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1, 23-35 (2007).
35. Melchjorsen, J., Siren, J., Julkunen, I., Paludan, S. R. & Matikainen, S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3. J. Gen.Virol. 87, 1099-1108 (2006).
36. Verpooten, D., Ma, Y., Hou, S., Yan, Z. & He, B. Control of TANK-binding kinase 1-mediated signaling by the γ134.5 protein of herpes simplex virus 1. J. Biol. Chem. 284, 1097-1105 (2009).
37. Jong, J. E., Park, J., Kim, S. & Seo, T. Kaposi's sarcoma-associated herpesvirus viral protein kinase interacts with RNA helicase A and regulates host gene expression. J. Microbiol. 48, 206-212 (2010).
38. Zhu, F. X., King, S. M., Smith, E. J., Levy, D. E. & Yuan, Y. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl Acad. Sci. USA 99, 5573-5578 (2002).
39. Jaworska, J., Gravel, A., Fink, K., Grandvaux, N. & Flamand, L. Inhibition of transcription of the β interferon gene by the human herpesvirus 6 immediate-early 1 protein. J. Virol. 81, 5737-5748 (2007).
40. Lubyova, B. & Pitha, P. M. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74, 8194-8201 (2000).
41. Taylor, R. T. & Bresnahan, W. A. Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor α-induced NFκB-dependent gene expression. J. Virol. 80, 10763-10771 (2006).
42. Cloutier, N. & Flamand, L. Kaposi sarcomaassociated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) β expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. J. Biol. Chem. 285, 7208-7221 (2010).
43. Sen, N. et al. Varicella zoster virus immediate early protein 62 blocks IRF3 phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 84, 9240-9253 (2010).
44. Akhtar, J. & Shukla, D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 276, 7228-7236 (2009).
45. Subramanian, R. P. & Geraghty, R. J. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc. Natl Acad. Sci. USA 104, 2903-2908 (2007).
46. Atanasiu, D., Saw, W. T., Cohen, G. H. & Eisenberg, R. J. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 84, 12292-12299 (2010).
47. Boehme, K. W., Guerrero, M. & Compton, T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177, 7094-7102 (2006).
48. Compton, T. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Tolllike receptor 2. J. Virol. 77, 4588-4596 (2003). This paper was the first to identify a TLR involved in the recognition of a herpesvirus.
49. Kurt-Jones, E. A. et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl Acad. Sci. USA 101, 1315-1320 (2004).
50. Sorensen, L. N. et al. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181, 8604-8612 (2008).
51. Wang, J. P. et al. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J. Virol. 79, 12658-12666 (2005).
52. Gaudreault, E., Fiola, S., Olivier, M. & Gosselin, J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 81, 8016-8024 (2007).
53. Sato, A., Linehan, M. M. & Iwasaki, A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl Acad. Sci. USA 103, 17343-17348 (2006).
54. Reske, A., Pollara, G., Krummenacher, C., Katz, D. R. & Chain, B. M. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180, 7525-7536 (2008).
55. Barbalat, R., Lau, L., Locksley, R. M. & Barton, G. M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nature Immunol. 10, 1200-1207 (2009).
56. Szomolanyi-Tsuda, E., Liang, X., Welsh, R. M., Kurt-Jones, E. A. & Finberg, R. W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80, 4286-4291 (2006).
57. Bochud, P. Y., Magaret, A. S., Koelle, D. M., Aderem, A. & Wald, A. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J. Infect. Dis. 196, 505-509 (2007).
58. Kijpittayarit, S., Eid, A. J., Brown, R. A., Paya, C. V. & Razonable, R. R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin. Infect. Dis. 44, 1315-1320 (2007).
59. Ahmad-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958-1968 (2002).
60. Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520 (2003).
61. Krug, A. et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103, 1433-1437 (2004).
62. Varani, S. et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J. Immunol. 179, 7767-7776 (2007).
63. Lim, W. H., Kireta, S., Russ, G. R. & Coates, P. T. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 109, 1043-1050 (2007).
64. Fiola, S., Gosselin, D., Takada, K. & Gosselin, J. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185, 3620-3631 (2010).
65. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516-3521 (2004).
66. Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119 (2004).
67. Guggemoos, S. et al. TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J. Immunol. 180, 438-443 (2008).
68. Yasuda, K. et al. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J. Immunol. 183, 3109-3117 (2009).
69. Haas, T. et al. The DNA sugar backbone 2 deoxyribose determines Toll-like receptor 9 activation. Immunity 28, 315-323 (2008).
70. Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777 (2005).
71. Delale, T. et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-α release and initiation of immune responses in vivo. J. Immunol. 175, 6723-6732 (2005).
72. Rasmussen, S. B. et al. Type I IFN production during HSV infection is controlled by cell-type specific viral recognition by TLR9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J. Virol. 81, 13315-13324 (2007).
73. Sarangi, P. P., Kim, B., Kurt-Jones, E. & Rouse, B. T. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J. Virol. 81, 11128-11138 (2007).
74. Lund, J. M., Linehan, M. M., Iijima, N. & Iwasaki, A. Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J. Immunol. 177, 7510-7514 (2006).
75. Wuest, T. et al. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 179, 46-52 (2006).
76. Zucchini, N. et al. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 180, 5799-5803 (2008).
77. Hokeness-Antonelli, K. L., Crane, M. J., Dragoi, A. M., Chu, W. M. & Salazar-Mather, T. P. IFN-αβ-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection. J. Immunol. 179, 6176-6183 (2007).
78. Ku, C. L. et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4- dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407-2422 (2007).
79. Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R. & Paludan, S. R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059-5064 (2006).
80. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (2001).
81. Iwakiri, D. et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206, 2091-2099 (2009).
82. Miettinen, M., Sareneva, T., Julkunen, I. & Matikainen, S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2, 349-355 (2001).
83. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640-643 (2003).
84. Schulz, O. et al. Toll-like receptor 3 promotes crosspriming to virus-infected cells. Nature 433, 887-892 (2005).
85. Davey, G. M. et al. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J. Immunol. 184, 2243-2246 (2010).
86. Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522-1527 (2007). This study showed that patients with TLR3 deficiency exhibit an impaired IFN response to HSV-1 infection in vitro and enhanced susceptibility to herpes simplex virus encephalitis.
87. Ranjith-Kumar, C. T. et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J. Biol. Chem. 282, 17696-17705 (2007).
88. Willmann, O., Ahmad-Nejad, P., Neumaier, M., Hennerici, M. G. & Fatar, M. Toll-like receptor 3 immune deficiency may be causative for HSV-2-associated mollaret meningitis. Eur. Neurol. 63, 249-251 (2010).
89. Sciortino, M. T., Suzuki, M., Taddeo, B. & Roizman, B. RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J. Virol. 75, 8105-8116 (2001).
90. Bresnahan, W. A. & Shenk, T. A subset of viral transcripts packaged within human cytomegalovirus particles. Science 288, 2373-2376 (2000).
91. Malmgaard, L., Melchjorsen, J., Bowie, A. G., Mogensen, S. C. & Paludan, S. R. Viral activation of macrophages through TLR-dependent and -independent pathways. J. Immunol. 173, 6890-6898 (2004).
92. Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T. & Takada, K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBo J. 25, 4207-4214 (2006).
93. Samanta, M., Iwakiri, D. & Takada, K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. oncogene 27, 4150-4160 (2008).
94. Melchjorsen, J. et al. Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III-independent pathways. J. Virol. 84, 11350-11358 (2010).
95. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730-737 (2004).
96. Ishii, K. J. et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nature Immunol. 7, 40-48 (2006).
97. Ishii, K. J. et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451, 725-729 (2008).
98. Defilippis, V. R. et al. Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B. J. Virol. 84, 8913-8925 (2010).
99. DeFilippis, V. R., Alvarado, D., Sali, T., Rothenburg, S. & Fruh, K. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J. Virol. 84, 585-598 (2010).
100. Cheng, G., Zhong, J., Chung, J. & Chisari, F. V. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc. Natl Acad. Sci. USA 104, 9035-9040 (2007).
101. Choi, M. K. et al. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc. Natl Acad. Sci. USA 106, 17870-17875 (2009).
102. Kim, T. et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 15181-15186 (2010).
103. Yan, H. et al. RPA nucleic acid-binding properties of IFI16-HIN200. Biochim. Biophys. Acta 1784, 1087-1097 (2008).
104. Mondini, M. et al. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity 43, 226-231 (2010).
105. Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nature Immunol. 11, 395-402 (2010). This work is the first to demonstrate an essential role for a cytoplasmic DNA sensor in the innate immune response to a herpesvirus (MCMV).
106. Hertel, L. et al. The interferon-inducible 204 gene, a member of the Ifi 200 family, is not involved in the antiviral state induction by IFN-α, but is required by the mouse cytomegalovirus for its replication. Virology 262, 1-8 (1999).
107. Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397-408 (2010).
108. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. & Iwasaki, A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 (2007).
109. Melchjorsen, J. & Paludan, S. R. Induction of RANTES/ CCL5 by herpes simplex virus is regulated by nuclear factor κB and interferon regulatory factor 3. J. Gen. Virol. 84, 2491-2495 (2003).
110. Delboy, M. G., Roller, D. G. & Nicola, A. V. Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J. Virol. 82, 3381-3390 (2008).
111. Soulat, D. et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1- dependent innate immune response. EMBo J. 27, 2135-2146 (2008).
112. Schroder, M., Baran, M. & Bowie, A. G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε- mediated IRF activation. EMBo J. 27, 2147-2157 (2008).
113. Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
114. Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferondependent innate immunity. Nature 461, 788-792 (2009).
115. Saitoh, T. et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl Acad. Sci. USA 106, 20842-20846 (2009).
116. Smiley, J. R. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J. Virol. 78, 1063-1068 (2004).
117. Kawai, T. & Akira, S. Innate immune recognition of viral infection. Nature Immunol. 7, 131-137 (2006).
118. Abate, D. A., Watanabe, S. & Mocarski, E. S. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol. 78, 10995-11006 (2004).
119. Browne, E. P. & Shenk, T. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl Acad. Sci. USA 100, 11439-11444 (2003).
120. McGregor, A., Liu, F. & Schleiss, M. R. Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83). J. Virol. 78, 9872-9889 (2004).
121. Leib, D. A. et al. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663-672 (1999).
122. Saira, K., Zhou, Y. & Jones, C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits β interferon promoter activity. J. Virol. 81, 3077-3086 (2007).
123. Paladino, P., Collins, S. E. & Mossman, K. L. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS oNE 5, e10428 (2010).
124. Melroe, G. T., Silva, L., Schaffer, P. A. & Knipe, D. M. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-β induction. Virology 360, 305-321 (2007).
125. Joo, C. H. et al. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81, 8282-8292 (2007).
126. Wies, E. et al. The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J. Biol. Chem. 284, 8525-8538 (2009).
127. Donaghy, H. et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 83, 1952-1961 (2009).
128. Sainz, B., Jr & Halford, W. P. α/β interferon and γ interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76, 11541-11550 (2002).
129. Gargano, L. M., Moser, J. M. & Speck, S. H. Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J. Virol. 82, 3853-3863 (2008).
130. Gregory, S. M. et al. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl Acad. Sci. USA 106, 11725-11730 (2009).
131. Gargano, L. M., Forrest, J. C. & Speck, S. H. Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J. Virol. 83, 1474-1482 (2009).
132. Kristensen, H. et al. Extracellular 2-5 oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J. Virol. 84, 11898-11904 (2010).
133. Haahr, S. & Hollsberg, P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev. Med. Virol. 16, 297-310 (2006).
134. Toussirot, E. & Roudier, J. Epstein-Barr virus in autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 22, 883-896 (2008).
135. Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Tolllike receptors. Nature 416, 603-607 (2002).
136. Kimkong, I., Avihingsanon, Y. & Hirankarn, N. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 18, 1066-1072 (2009).
137. Mondini, M. et al. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann. NY Acad. Sci. 1110, 47-56 (2007).
138. Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308-312 (2006).
139. Diego, R. P. et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33, 400-411 (2010).
140. Ariza, M. E., Glaser, R., Kaumaya, P. T., Jones, C. & Williams, M. V. The EBV-encoded dUTPase activates NF-κB through the TLR2 and MyD88-dependent signaling pathway. J. Immunol. 182, 851-859 (2009).